Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3

Clinical trial NCT05541107 · UNKNOWN

Trial details

NCT number: NCT05541107
Sponsor: Matinas BioPharma Nanotechnologies, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cryptococcal Meningitis

Start date: 2023-01-01
Primary completion: 2024-10-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.